Navigation Links
Jentadueto® (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of adults with type 2 diabetes in Europe
Date:5/29/2012

RIDGEFIELD, Conn. and INDIANAPOLIS, May 29, 2012 /PRNewswire/ -- Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced they have received a positive opinion from the European Medicines Agency's (EMA) medicinal committee recommending approval of Jentadueto® (linagliptin/metformin hydrochloride) tablets, a medicine combining the DPP-4 inhibitor, linagliptin (the active ingredient in Tradjenta® tablets, marketed under the trade name Trajenta® in Europe) and metformin in a single tablet taken twice daily.(1)

The EMA's Committee for Medicinal Products for Human Use (CHMP) recommended the approval of JENTADUETO for use alongside diet and exercise to improve glycemic control in adults with type 2 diabetes who are inadequately controlled on their maximally tolerated dose of metformin alone or those already being treated with the combination of linagliptin and metformin. If approved by the European Commission, JENTADUETO will provide a new, single-tablet treatment option, taken twice daily, for adults with type 2 diabetes who need to improve control of their blood glucose.(2)

"The CHMP positive opinion for JENTADUETO marks another important regulatory milestone for the Boehringer Ingelheim and Eli Lilly and Company worldwide diabetes alliance, extending our commitment to bringing new medicines to those patients who need them," said Prof. Klaus Dugi, Corporate Senior Vice President Medicine, Boehringer Ingelheim. "Around the world, many people with type 2 diabetes require more than one treatment to adequately manage their blood sugar. By combining two important diabetes medicines in a single tablet, we believe that JENTADUETO will provide people with type 2 diabetes another way of improving control of their blood sugar."

JENTADUETO was approved by the U.S. Food and Drug Administration (FDA) in January 2012 as a prescription medicine used along with diet and exercise to improve glycemic control i
'/>"/>

SOURCE Eli Lilly and Company; Boehringer Ingelheim
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Boehringer Ingelheim and Lillys new oral type 2 diabetes treatment for adults, Jentadueto™ (linagliptin/metformin hydrochloride) tablets, now available in U.S. pharmacies
2. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
3. Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm
4. Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session
5. Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) Capsules at the American Academy of Pain Management Annual Clinical Meeting
6. Shionogi Inc. Announces Commercial Availability of KAPVAY™ (clonidine hydrochloride) Extended-Release Tablets for the Treatment of ADHD
7. Shionogi Inc. Announces Publication of Data in Pediatrics Demonstrating Efficacy of KAPVAY™ (clonidine hydrochloride) Extended-Release Tablets as Add-On Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents
8. Breckenridge Pharmaceutical Announces Settlement of Actos® (Pioglitazone Hydrochloride) Patent Litigation
9. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
10. New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR(R) (zolpidem tartrate extended-release) Tablets CIV
11. A Phase II, Randomized, Double Blind, Placebo-Controlled Dose-Escalating Study, Meets the Clinical Endpoints of MTR106 Tablets During the Treatment of Acute Migraine Attacks Without Aura in Females
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015  Johnson & Johnson (NYSE: ... at 10 a.m. (Eastern Time) on Thursday, April 23, 2015, ... Investors and other interested parties may ... the Company,s website at www.jnj.com and clicking on ... the meeting will be made available a few hours after ...
(Date:3/27/2015)... March 27, 2015  WebMD Health Corp. ... of health information, today announced an exclusive ... National Action Plan for Combating Antibiotic-Resistant Bacteria ... the urgency and importance of addressing antibiotic-resistant ... global health.    The WebMD interview, ...
(Date:3/26/2015)... -- "Whether it,s our family, our friends, all of ... a single sentence, Dr. Anthony Coyle , senior ... Centers for Therapeutic Innovation (CTI), sums up what ... biopharmaceutical companies. CTI,s unique model allows ... and the National Institutes of Health (NIH) to bridge ...
Breaking Medicine Technology:Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 2Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 3Collaboration for Cures: Teaming Up to Advance Science and Save Lives 2
... Sequenom, Inc. (NASDAQ: SQNM ), a life sciences company ... results for the third quarter of 2011 after closing of the ... conference call hosted by Harry F. Hixson, Jr., Ph.D., Chairman and ... the same day at 5:00pm ET (2:00pm PT) and will be ...
... STAAR Surgical Company (NASDAQ: STAA ) ... the third quarter ended September 30, 2011. The Company ... final results on Monday, October 24, 2011 in order ... other attendees of the American Association of Ophthalmology (AAO) ...
Cached Medicine Technology:Sequenom, Inc. Announces Date of Third Quarter 2011 Financial Results and Conference Call 2STAAR Surgical Provides Outlook on Third Quarter 2011 Revenue and Cash 2STAAR Surgical Provides Outlook on Third Quarter 2011 Revenue and Cash 3STAAR Surgical Provides Outlook on Third Quarter 2011 Revenue and Cash 4STAAR Surgical Provides Outlook on Third Quarter 2011 Revenue and Cash 5
(Date:3/27/2015)... 2015 Approximately 300 advocates participated ... Coalition Lobby Day to lobby for physical education, ... (SHIP). Everlast Climbing was especially interested in ... which would strengthen physical education programs by adopting ... other measures to strengthen physical education in schools. ...
(Date:3/27/2015)... New Jersey (PRWEB) March 27, 2015 ... singer-songwriter-actress has released the official music video for her ... label. , Combining live-action and abstract styling effects, ... can be viewed on YouTube, Vimeo, and assorted outlets. ... in the development of an expanding full-scale marketing strategy. ...
(Date:3/27/2015)... April 2015 is the 150th anniversary of the end of ... war and the amazing President that led our country through ... Civil War and Abraham Lincoln. This moving event will be ... Pickens Theater in Newport, RI. , Chief Justice (Ret.) ... master of ceremonies. Dr. Fred Zilian, educator, writer and actor, ...
(Date:3/27/2015)... DC (PRWEB) March 27, 2015 The ... with Accelerate Brain Cancer Cure (ABC2), awarded $350,000 to ... University of Florida, The Scripps Research Institute and H. ... awards support studies with a clear development path and ... patients in the near future. , The awards ...
(Date:3/26/2015)... March 27, 2015 Moreno Ranches, a ... announce prestigious victories at the 2015 International Brahman Show ... quite successful across many categories of show cattle for ... at the ABBA International Brahman show,” explained Kelvin Moreno, ... and the proof of our superior genetics is in ...
Breaking Medicine News(10 mins):Health News:Everlast Climbing Advocates to Strengthen Physical Education in Minnesota Schools 2Health News:Airy Jeanine Releases ‘’Mama’s Girl” Official Music Video 2Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 2Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 3Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 4Health News:The Florida Center for Brain Tumor Research and Accelerate Brain Cancer Cure Award $350,000 to Florida-Based Researchers 2Health News:The Florida Center for Brain Tumor Research and Accelerate Brain Cancer Cure Award $350,000 to Florida-Based Researchers 3Health News:Red and Gray Brahman Cattle Champions Announced by Moreno Ranches at International Brahman Show and Sale in Houston, Texas 2
... 2008 Studies published in a special issue of the ... by the University of California Press reveal that abstinence-only-until-marriage ... teenagers, provide inaccurate information about condoms, and violate human ... professor and chair of the Heilbrunn Department of Family ...
... had a twenty-five percent increase in the number of air ambulance ... ... Scottsdale, AZ (PRWEB) September 16, 2008 -- Angel MedFlight ... increase in the number of air ambulance flights they operated in ...
... OAK BROOK, Ill. Canadian researchers have used three-dimensional magnetic ... walls of diseased carotid arteries, a condition that may lead ... the October issue of Radiology suggest the technique ... at high risk for stroke. , When major arteries ...
... Not yet. But a new study offers new evidence ... help. The three-year study showed that trial participants who ... a "Jackson" cold or flu. The very sensitive Jackson ... clinical symptoms, which include coughing, sneezing, runny noses and ...
... Not only restores aesthetics, but also improves speech recognition ... can help improve hearing and speech recognition for people ... cancer surgery, a new U.S. study reports. , In ... lost, the external auditory canal is usually intact, and ...
... Scientists and clinicians from around the world will ... American Association for Cancer Research,s third International Conference ... The conference is subtitled, "Fulfilling the Promise of ... diagnostics to provide new strategies for tailoring therapies ...
Cached Medicine News:Health News:Accuracy, efficacy and ethics of abstinence-only programs questioned by public health experts 2Health News:Accuracy, efficacy and ethics of abstinence-only programs questioned by public health experts 3Health News:Accuracy, efficacy and ethics of abstinence-only programs questioned by public health experts 4Health News:Substantial Second Quarter Surge for Angel MedFlight Worldwide Air Ambulance Services 2Health News:3-D MRI technique helps radiologists detect high-risk carotid disease 2Health News:Colds and flu cut by one-third in study of Canada's top cold fighter in vaccinated seniors 2Health News:Colds and flu cut by one-third in study of Canada's top cold fighter in vaccinated seniors 3Health News:Prosthetic Ears Boost Hearing After Injury 2Health News:Scientists take cancer research back to the basic molecular level 2
... determination of Estradiol (E2) concentration in human serum ... hormone with a phenolic A ring. This ... It is the most potent natural Estrogen, ... smaller amounts by the adrenal cortex, and the ...
... potent, naturally secreted estrogen and is the ... In the ovary, estradiol is produced from ... potent estrogen derived from androstenedione. Estrone and ... In men, small amounts of estradiol are ...
... VITROS ECi brings true automation and ... testing. Highly sensitive assays for thyroid, ... bone metabolism testing are currently available, ... The VITROS ECi can simultaneously process ...
Clinical marker immunoassay kit for detection of Myoglobin....
Medicine Products: